eNews
Home page > Comments


Comments

ThromboGenics says U.S. authorities clear its main drug

18.10.2012. | BRUSSELS (Reuters) - Belgian biotech company ThromboGenics said on Thursday that U.S. health regulators had approved the use of its main drug, eye treatment Jetrea....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: